Dr. Stover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 Olentangy River Rd
Columbus, OH 43212Phone+1 614-293-0066Fax+1 614-293-7264
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2012
Vanderbilt University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2017 - 2026
MA State Medical License 2012 - 2019
TN State Medical License 2010 - 2013- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 522 citationsGenomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.Yi-Zhou Jiang, Ding Ma, Chen Suo, Shi Jinxiu, Mengzhu Xue
Cancer Cell. 2019-03-18 - 138 citationsAssociation of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.Daniel G. Stover, Heather A. Parsons, Gavin Ha, Samuel S. Freeman, William T. Barry
Journal of Clinical Oncology. 2018-01-03 - 322 citationsCDK7-Dependent Transcriptional Addiction in Triple-Negative Breast CancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, Brian J. Abraham, Tong Ihn Lee
Cell. 2015-09-24
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
Press Mentions
New Hormonal Treatment Orserdu Approved for Metastatic Breast CancerFebruary 13th, 2023- Twitter: Dr Toni Choueiri – FDA Approve Pembrolizumab Top Tweet Q4 2021November 4th, 2021
- De-Escalation of Radiation Therapy in Patients with Stage I, Node-Negative, HER2-Positive Breast CancerMarch 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
